Advertisement
Screener

Beam Therapeutics Inc. (BEAM) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Beam Therapeutics Inc. Cash Flow Breakdown

Cash flow breakdown shows where Beam Therapeutics Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $345.10M went out.
  • Fiscal year ended 2025-12-31: from investing, $121.44M went out.
  • Fiscal year ended 2025-12-31: from financing, $478.05M came in.
  • Fiscal year ended 2025-12-31: change in cash, $11.51M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$345.10M-$121.44M$4.77M$473.28M*$11.51M
2024-12-31-$347.25M$185.01M$5.60M$2.14M*-$154.50M
2023-12-31-$149.19M$71.84M$236.57M$39.88M*$199.09M
2022-12-31$22.53M-$461.34M$108.26M$3.33M*-$327.22M
2021-12-31-$66.27M-$294.14M$757.45M-$1.31M*$395.73M
2020-12-31-$95.74M-$100.12M$3.15M$319.17M*$126.46M
2019-12-31-$72.00M-$66.66M$185.00K$41.09M*-$97.38M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$66.10M*-$9.88M*$7.52M*
2026-03-31-$128.51M$25.27M$2.02M$94.58M*-$6.64M
2025-12-31-$83.29M*$108.41M*$1.89M*
2025-09-30-$81.48M*$65.66M*$412.00K*$1.26M*
2025-06-30-$76.45M*-$170.41M*$1.75M*-$646.00K*
2025-03-31-$103.88M-$125.09M$719.00K$472.66M*$244.41M
2024-12-31-$76.36M*$126.28M*$3.44M*
2024-09-30-$88.13M*$24.70M*$239.00K*$1.02M*
2024-06-30-$83.01M*$87.49M*$240.00K*
2024-03-31-$99.75M-$53.46M$1.68M$1.22M*-$150.31M
2023-12-31$135.07M*$98.10M*$745.00K*$32.97M*
2023-09-30-$89.78M*-$10.23M*$34.95M*$1.83M*
2023-06-30-$84.67M*-$41.48M*$107.64M*
2023-03-31-$109.81M$25.45M$93.98M$4.43M*$14.05M
2022-12-31-$69.19M*$113.44M*$31.89M*
2022-09-30-$74.50M*-$36.17M*$0.00*$1.56M*
2022-06-30-$52.28M*-$1.26M*$22.36M*
2022-03-31$218.49M-$537.34M$54.00M$1.67M*-$263.17M
2021-12-31$1.83M*-$77.50M*$20.24M*$1.30M*
2021-09-30$3.01M*$76.11M*$318.92M*$1.96M*
2021-06-30-$32.53M*-$13.14M*$158.28M*$2.16M*
2021-03-31-$38.58M-$279.63M$260.00M-$6.73M*-$64.93M
2020-12-31-$24.30M*-$81.43M*$2.09M*$127.91M*
2020-09-30-$21.21M*$35.23M*$557.00K*
2020-06-30-$22.84M*$22.87M*$360.00K*-$1.14M*
2020-03-31-$27.39M-$76.79M$152.00K$192.86M*$88.83M
2019-12-31-$17.80M*$16.56M*$49.00K*$650.00K*
2019-09-30-$16.99M*$14.21M*$81.00K*$2.61M*
2019-06-30-$11.35M*-$95.08M*$48.00K*
2019-03-31-$25.86M-$2.35M$7.00K$37.90M*$9.70M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Greenland Mines Ltd (GRML)United States$2.362B
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
NOVAVAX INC (NVAX)United States$1.748B-6.26